The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000788370p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
29/05/2026
Date registered
Help: Date registered
1/07/2026
Date last updated
Help: Date last updated
1/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
1/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Online Cognitive Training to Prevent PTSD and Depression in Early Career Military Personnel: A Randomised Controlled Trial
Scientific title
Internet-Delivered Cognitive Training in Resilience for Preventing PTSD and Depression in Early Career Military Personnel: A Randomised Controlled Trial
Additional trial identifiers [1] 317409 0
Nil known
Universal Trial Number (UTN)
Trial acronym
PREVENT-PTSD
Related trial records

Health condition
Health condition(s) studied:
Posttraumatic Stress Disorder 342072 0
Major Depressive Disorder 342073 0
Condition category
Condition code
Mental Health 338183 338183 0 0
Other mental health disorders
Mental Health 338184 338184 0 0
Depression

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Internet-delivered cognitive training in resilience (iCT-R)

Internet-delivered cognitive training in resilience (iCT-R) is a coach-supported, 6-module program delivered online over 6 weeks, with modules sent to participants by email each week. Each module targets modifiable cognitive risk factors implicated in the development of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD), including rumination and unhelpful beliefs about resilience. Each module takes approximately 20 minutes to complete. iCT-R adopts an active, experiential approach in which participants develop practical skills through exercises and videos, and are given tasks to apply and practise strategies in their daily life between modules. Following each completed module, a trained coach reviews the participant's responses and provides personalised written feedback by email, based on a structured template, to consolidate learning, address difficulties, and encourage continued engagement. iCT-R is distinct from psychoeducation in that it trains participants to actively modify their own cognitive and behavioural risk factors, equipping them with tools to reduce their risk of developing PTSD or depression following exposure to traumatic or operational stressors.

iCT-R comprises six modules, each targeting a specific cognitive or behavioural risk factor for PTSD and depression. The intervention content and delivery format are described in full in Wild et al. (2018, 2026). Module 1 (It Matters What You Focus On: Helpful and Unhelpful Attention) focuses on attention; Module 2 (Get Out of Your Head with Helpful Thinking) introduces flexible thinking; Module 3 (Habits and Dwelling: How to Change Them) covers rumination; Module 4 (Dealing with Unwanted Memories: Then vs Now) teaches a tool to reduce the frequency of unwanted memories; Module 5 (Transforming Worries and Improving Performance) addresses worries, and Module 6 (Beating Stress and Trauma: My Blueprint) consolidates learning from the program and covers how to respond to early symptoms of PTSD and depression.
Intervention code [1] 334204 0
Prevention
Intervention code [2] 334358 0
Behaviour
Description of the comparator or control
Standard practice

Participants allocated to the standard practice condition will have access to standard Defence mental health support as needed, including the Australian Defence Force (ADF) All Hours Support Line, Open Arms Veterans and Family Counselling, and routine medical and psychological services. They will not receive any additional intervention as part of the study. This condition reflects the current standard of care available to early career ADF members and provides an ecologically valid comparator for evaluating the additive benefit of iCT-R. Participants in the standard practice condition will be offered iCT-R at 12 months follow-up should they wish to receive it.
Control group
Active

Outcomes
Primary outcome [1] 345556 0
PTSD symptom severity
Timepoint [1] 345556 0
Baseline, 8 weeks post-randomisation, and 60 weeks post-randomisation (primary time point).
Primary outcome [2] 345557 0
Depression symptom severity
Timepoint [2] 345557 0
Baseline, 8 weeks post-randomisation, and 60 weeks post-randomisation (primary time point).
Secondary outcome [1] 462147 0
Rate of probable PTSD
Timepoint [1] 462147 0
Baseline, 8 weeks and 60 weeks post-randomisation
Secondary outcome [2] 462148 0
Rate of probable depression
Timepoint [2] 462148 0
Baseline, 8 weeks and 60 weeks post-randomisation
Secondary outcome [3] 462149 0
Rumination
Timepoint [3] 462149 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [4] 462150 0
Socially anxious thoughts
Timepoint [4] 462150 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [5] 462151 0
Negative trauma-related cognitions
Timepoint [5] 462151 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [6] 462152 0
Anxiety symptom severity
Timepoint [6] 462152 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [7] 462153 0
Complex PTSD symptom severity
Timepoint [7] 462153 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [8] 462154 0
Self-focussed attention
Timepoint [8] 462154 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [9] 462155 0
Resilience appraisals
Timepoint [9] 462155 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [10] 462156 0
Health-related quality of life
Timepoint [10] 462156 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [11] 462157 0
Capability wellbeing
Timepoint [11] 462157 0
Baseline, 8 weeks post-randomisation, 60 weeks post-randomisation
Secondary outcome [12] 462158 0
Incremental cost per case of probable PTSD prevented, defined as a PCL-5 score of 31 or above, comparing iCT-R with standard practice at 60 weeks post-randomisation
Timepoint [12] 462158 0
Baseline, 60 weeks post-randomisation
Secondary outcome [13] 463128 0
Incremental cost per case of probable depression prevented, defined as a PHQ-8 score of 10 or above, comparing iCT-R with standard practice at 60 weeks post-randomisation
Timepoint [13] 463128 0
Baseline, 60 weeks post-randomisation
Secondary outcome [14] 463129 0
Intervention delivery costs (comprising coach costs, platform costs and training and supervision costs) comparing iCT-R with standard practice at 60 weeks post-randomisation
Timepoint [14] 463129 0
Coach logs recorded continuously through weeks 1 through 8; Platform costs as a total annual licensing cost allocated per participant across the full study period (60 weeks); Training recorded at the outset prior to participant enrolment; Supervision recorded continuously throughout the study period

Eligibility
Key inclusion criteria
Current serving Australian Defence Force early career military members aged 18 years or older, completing initial employment training, fluent in English, have regular access to an internet-abled device, and are willing to be randomly allocated to study condition.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Meeting PCL-5 criteria for probable PTSD, meeting PHQ-8 criteria for probable Major Depressive Disorder, declines randomisation.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation will be prepared by an individual independent of the research team.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Participants will be randomly allocated to the intervention or standard practice on a 1:1 ratio using a computer-generated randomisation sequence stratified by baseline PCL-5 symptom severity score and gender.
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
The primary outcome measures (PTSD and depression symptom severity scores) will be analysed using linear mixed-effects models. Models will include categorical fixed factors of time (post-intervention and 12-month follow-up), condition (iCT-R and standard practice), and the time-by-condition interaction, which permits estimation of differences between conditions at each time point. The stratification variables of baseline PCL-5 symptom severity score and gender will be included as fixed covariates, along with the baseline score on the measure being analysed. Participant will be specified as a random effect to account for between-subject variation. Linear models will use restricted maximum likelihood estimation. This approach has the advantage of including all available data, accounting for repeated measures, and implicitly accounting for data missing at random.
Secondary analyses of probable PTSD and depression caseness rates will use mixed-effects logistic regression following the same model specification, with maximum likelihood estimation.

All analyses will use the intention-to-treat sample unless otherwise specified. Baseline clinical and demographic variables will be examined as possible predictors of missingness on the primary outcome at 12-month follow-up, and any variable showing a significant predictive association will be included as an additional covariate in a sensitivity analysis of the primary model.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 321981 0
Government body
Name [1] 321981 0
Department of Defence
Country [1] 321981 0
Australia
Primary sponsor type
Individual
Name
Jennifer Wild - Department of Psychiatry, University of Melbourne
Address
Country
Australia
Secondary sponsor category [1] 324858 0
Government body
Name [1] 324858 0
Joint Health Command, Department of Defence
Address [1] 324858 0
Country [1] 324858 0
Australia
Other collaborator category [1] 283967 0
University
Name [1] 283967 0
Flinders University
Address [1] 283967 0
Country [1] 283967 0
Australia

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320520 0
Department of Defence and Veterans’ Affairs Human Research Ethics Committee
Ethics committee address [1] 320520 0
Ethics committee country [1] 320520 0
Australia
Date submitted for ethics approval [1] 320520 0
22/05/2026
Approval date [1] 320520 0
Ethics approval number [1] 320520 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150730 0
Prof Jennifer Wild
Address 150730 0
Phoenix Australia Centre for Posttraumatic Mental Health, Department of Psychiatry, University of Melbourne, 161 Barry Street, Carleton, Victoria 3053
Country 150730 0
Australia
Phone 150730 0
+61 448005964
Fax 150730 0
Email 150730 0
Contact person for public queries
Name 150731 0
Jennifer Wild
Address 150731 0
Phoenix Australia Centre for Posttraumatic Mental Health, Department of Psychiatry, University of Melbourne, 161 Barry Street, Carleton, Victoria 3053
Country 150731 0
Australia
Phone 150731 0
+61 448005964
Fax 150731 0
Email 150731 0
Contact person for scientific queries
Name 150732 0
Jennifer Wild
Address 150732 0
Phoenix Australia Centre for Posttraumatic Mental Health, Department of Psychiatry, University of Melbourne, 161 Barry Street, Carleton, Victoria 3053
Country 150732 0
Australia
Phone 150732 0
+61 448005964
Fax 150732 0
Email 150732 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.